ArticleJCO precision oncology2020

CES2 Expression in Pancreatic Adenocarcinoma Is Predictive of Response to Irinotecan and Is Associated With Type 2 Diabetes.

Michela Capello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.